Role of FGF10 in liver organogenesis and alcohol-impaired regeneration

FGF10 在肝器官发生和酒精损伤再生中的作用

• 批准号: 7918768
• 负责人: KASPER SAONUN WANG
• 金额: $ 17.39万
• 依托单位: CHILDREN'S HOSPITAL OF LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-25 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7918768
• 关键词: Adult; Alcohol abuse; Alcoholic Liver Diseases; Alcohols; Artificial Liver; Cell Proliferation; Cell Separation; Cells; Cirrhosis; Data; Dependence; Development; Dominant-Negative Mutation; Embryo; Embryonic Development; Endoderm; Epithelium; Ethanol; Exhibits; Fibroblast Growth Factor Receptor 2; Fluorescence; Fluorescence-Activated Cell Sorting; Galactosidase; Gastrointestinal tract structure; Genes; Growth Factor; Health; Healthcare; Hepatectomy; Hepatic; Hepatic Fibrogenesis; Hepatic Stellate Cell; Hepatocyte; Hydrolysis; Immunofluorescence Immunologic; Impairment; In Vitro; Ingestion; LacZ Genes; Lead; Ligands; Liver; Liver Cirrhosis; Liver Regeneration; Liver diseases; Mediating; Mesenchymal; Mesenchyme; Mesoderm; Methods; Modeling; Molecular; Morbidity - disease rate; Mus; Mutant Strains Mice; Myofibroblast; Natural regeneration; Nuclear Translocation; Organogenesis; Partial Hepatectomy; Pathway interactions; Pattern; Play; Population; Prevention; Primitive foregut structure; Process; Protein Isoforms; Relative (related person); Reporter; Research Personnel; Role; Signal Transduction; Societies; Sorting - Cell Movement; Staging; Stem cells; Time; Transgenic Mice; Transgenic Organisms; United States; Up-Regulation; WNT Signaling Pathway; autocrine; base; cell type; cost; early embryonic stage; feeding; fetal; fibroblast growth factor 10; gain of function; in vivo; insight; intestinal crypt; liver transplantation; loss of function; mortality; mutant; novel; organ regeneration; oval cell; overexpression; postnatal; programs; receptor; repaired; response to injury; stellate cell

DESCRIPTION (provided by applicant): This proposal focuses on the potential role of reduced FGF10 signaling in the setting of ethanol (EtOH) impaired liver regeneration. FgflO, expressed in the embryonic foregut mesoderm, normally interacts with the adjacent endoderm through Fibroblast Growth Factor Receptor 2 1Mb (FGFR2b). Absence of signaling through FGFR2b results in atresias of numerous gastrointestinal tract structures. We have preliminary evidence showing that FGF10 activates canonical WNT signaling in the developing liver through FGFR2b. Our studies indicate that Fgf 10 is expressed by activated hepatic stellate cells, which play a key role in liver fibrogenesis, and that Fgfr2b is expressed by progenitor cells, hepatoblasts prenatally and oval cells postnatally. Consistent with the observation that FGFR2b signaling is activated during liver regeneration, we have evidence that Fgf 10 expression, which is upregulated after partial hepatectomy, is reduced in the setting of ethanol-induced impaired liver regeneration. We hypothesize that ethanol suppresses signaling through the FGF10/FGFR2b, thus, impairing progenitor cell proliferation. We thus propose the following specific aims: (1) To determine the role of FGF10 signaling via FGFR2b during liver regeneration following partial hepatectomy (PH) in the absence or presence of EtOH in transgenic mice. Liver-specific induced overexpression of the dominant negative soluble FGFR2b isoform or of Fgf 10 in the setting of EtOH impaired liver regeneration following PH will be performed for loss-of-function or gain-of-function analyses, respectively. (2) To determine the identity and role of Fgf 10-expressing cells in hepatogenesis and EtOHimpaired liver regeneration. Cells expressing Fgf 10 from transgenic embryo livers and PH livers exposed to EtOH will be sorted by fluorescence activated cell sorting (FACS) and characterized by real-time PCR. (3) To determine the identity of cells undergoing FGF10-mediated canonical WNT activation. Cells with activated canonical WNT signaling will be sorted by FACS. Loss and gain-of function analyses for FgflO will be performed to determine relative levels of canonical WNT activiation. Alcohol impairs the liver's ability to repair and regenerate itself. This contributes to the development of liver cirrhosis. We postulate that the mechanism by which alcohol impairs liver regeneration may be due to impaired signaling through the FGF10/FGFR2b pathway we show normally promotes liver regeneration.

描述（由申请人提供）：该提案的重点是降低FGF10信号在乙醇（ETOH）受损的肝脏再生中的潜在作用。 FGFLO在胚胎前肠中表达，通常通过成纤维细胞生长因子受体2 1MB（FGFR2B）与相邻内胚层相互作用。通过FGFR2B没有信号导致许多胃肠道结构的闭锁。我们有初步证据表明，FGF10通过FGFR2B激活了发育中的肝脏中的规范Wnt信号。我们的研究表明，FGF 10由活化的肝星状细胞表达，在肝纤维发生中起关键作用，而FGFR2B用祖细胞表达，肝细胞在产前和椭圆形细胞表达。与观察到肝脏再生过程中FGFR2B信号传导被激活的观察结果，我们有证据表明，在乙醇诱导的肝脏再生受损的情况下，FGF 10表达在部分肝切除术后被上调。我们假设乙醇通过FGF10/FGFR2B抑制信号传导，从而损害了祖细胞的增殖。因此，我们提出以下内容 具体目的：（1）在转基因小鼠中不存在或存在ETOH的情况下，在部分肝切除术（PH）后通过FGFR2B确定FGF10信号传导的作用。在ETOH受损后，将分别进行肝脏可溶性FGFR2B同工型或FGF 10的肝脏特异性诱导的过表达。 （2）确定FGF 10表达细胞在肝脏发生和eToH型肝脏再生中的身份和作用。从传染到ETOH的转基因胚胎肝和pH肝脏表达FGF 10的细胞将通过荧光激活的细胞分选（FACS）进行分类，并以实时PCR为特征。 （3）确定经历FGF10介导的规范Wnt激活的细胞的身份。具有激活的规范Wnt信号传导的细胞将由FACS分类。将对FGFLO进行损失和功能分析，以确定规范WNT激活的相对水平。酒精会损害肝脏修复和再生的能力。这有助于肝硬化的发展。我们假设酒精会损害肝脏再生的机制可能是由于通过FGF10/FGFR2B途径的信号受损而导致的，我们通常显示出促进肝脏再生。

项目成果

Fibroblast growth factor signaling regulates the expansion of A6-expressing hepatocytes in association with AKT-dependent β-catenin activation.

• DOI: 10.1016/j.jhep.2013.12.017
• 发表时间: 2014-05
• 期刊: JOURNAL OF HEPATOLOGY
• 影响因子: 25.7
• 作者: Utley, Sarah;James, David;Mavila, Nirmala;Nguyen, Marie V.;Vendryes, Christopher;Salisbury, S. Michael;Phan, Jennifer;Wang, Kasper S.
• 通讯作者: Wang, Kasper S.